Literature DB >> 24082076

Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size.

Jiri Masin1, Radovan Fiser, Irena Linhartova, Radim Osicka, Ladislav Bumba, Erik L Hewlett, Roland Benz, Peter Sebo.   

Abstract

A large subgroup of the repeat in toxin (RTX) family of leukotoxins of Gram-negative pathogens consists of pore-forming hemolysins. These can permeabilize mammalian erythrocytes (RBCs) and provoke their colloid osmotic lysis (hemolytic activity). Recently, ATP leakage through pannexin channels and P2X receptor-mediated opening of cellular calcium and potassium channels were implicated in cell permeabilization by pore-forming toxins. In the study described here, we examined the role played by purinergic signaling in the cytolytic action of two RTX toxins that form pores of different sizes. The cytolytic potency of ApxIA hemolysin of Actinobacillus pleuropneumoniae, which forms pores about 2.4 nm wide, was clearly reduced in the presence of P2X7 receptor antagonists or an ATP scavenger, such as pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS), Brilliant Blue G, ATP oxidized sodium salt, or hexokinase. In contrast, antagonists of purinergic signaling had no impact on the hemolytic potency of the adenylate cyclase toxin-hemolysin (CyaA) of Bordetella pertussis, which forms pores of 0.6 to 0.8 nm in diameter. Moreover, the conductance of pores formed by ApxIA increased with the toxin concentration, while the conductance of the CyaA single pore units was constant at various toxin concentrations. However, the P2X7 receptor antagonist PPADS inhibited in a concentration-dependent manner the exacerbated hemolytic activity of a CyaA-ΔN489 construct (lacking 489 N-terminal residues of CyaA), which exhibited a strongly enhanced pore-forming propensity (>20-fold) and also formed severalfold larger conductance units in planar lipid bilayers than intact CyaA. These results point to a pore size threshold of purinergic amplification involvement in cell permeabilization by pore-forming RTX toxins.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24082076      PMCID: PMC3837988          DOI: 10.1128/IAI.00711-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  79 in total

1.  Channel formation in model membranes by the adenylate cyclase toxin of Bordetella pertussis: effect of calcium.

Authors:  Oliver Knapp; Elke Maier; Georg Polleichtner; Jirí Masín; Peter Sebo; Roland Benz
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

2.  Pannexin membrane channels are mechanosensitive conduits for ATP.

Authors:  Li Bao; Silviu Locovei; Gerhard Dahl
Journal:  FEBS Lett       Date:  2004-08-13       Impact factor: 4.124

3.  An ATP-activated conductance in pheochromocytoma cells and its suppression by extracellular calcium.

Authors:  K Nakazawa; K Fujimori; A Takanaka; K Inoue
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

Review 4.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

5.  The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase is crucial for toxin function independently of its acylation status.

Authors:  T Basar; V Havlícek; S Bezousková; P Halada; M Hackett; P Sebo
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

6.  Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes.

Authors:  T Rose; P Sebo; J Bellalou; D Ladant
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

7.  Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes.

Authors:  Peter Svenssen Munksgaard; Thomas Vorup-Jensen; Jesper Reinholdt; Carl Martin Söderström; Knud Poulsen; Jens Leipziger; Helle A Praetorius; Marianne Skals
Journal:  Cell Microbiol       Date:  2012-09-25       Impact factor: 3.715

8.  Direct actions of carbenoxolone on synaptic transmission and neuronal membrane properties.

Authors:  Kenneth R Tovar; Brady J Maher; Gary L Westbrook
Journal:  J Neurophysiol       Date:  2009-06-17       Impact factor: 2.714

9.  Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.

Authors:  S Bhakdi; N Mackman; J M Nicaud; I B Holland
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

10.  Alpha-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis.

Authors:  Marianne Skals; Niklas R Jorgensen; Jens Leipziger; Helle A Praetorius
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

View more
  23 in total

Review 1.  Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme.

Authors:  Jiri Masin; Radim Osicka; Ladislav Bumba; Peter Sebo
Journal:  Pathog Dis       Date:  2015-09-20       Impact factor: 3.166

2.  Purinergic control of lysenin's transport and voltage-gating properties.

Authors:  Sheenah Bryant; Nisha Shrestha; Paul Carnig; Samuel Kosydar; Philip Belzeski; Charles Hanna; Daniel Fologea
Journal:  Purinergic Signal       Date:  2016-06-18       Impact factor: 3.765

3.  Loop Diuretics Diminish Hemolysis Induced by α-Hemolysin from Escherichia coli.

Authors:  Carl Martin Söderström; Steen K Fagerberg; Mette B Brogaard; Jens Leipziger; Marianne Skals; Helle A Praetorius
Journal:  J Membr Biol       Date:  2017-05-09       Impact factor: 1.843

4.  Generation of a recombinant Aggregatibacter actinomycetemcomitans RTX toxin in Escherichia coli.

Authors:  Nataliya Balashova; Alexander Giannakakis; Angela C Brown; Evan Koufos; Roland Benz; Tsutomu Arakawa; Hsin-Yao Tang; Edward T Lally
Journal:  Gene       Date:  2018-06-04       Impact factor: 3.688

5.  [Ca2+]i Oscillations and IL-6 Release Induced by α-Hemolysin from Escherichia coli Require P2 Receptor Activation in Renal Epithelia.

Authors:  Mette G Christensen; Steen K Fagerberg; Pauline I de Bruijn; Randi G Bjaelde; Helle Jakobsen; Jens Leipziger; Marianne Skals; Helle A Praetorius
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

6.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

7.  Retargeting from the CR3 to the LFA-1 receptor uncovers the adenylyl cyclase enzyme-translocating segment of Bordetella adenylate cyclase toxin.

Authors:  Jiri Masin; Adriana Osickova; David Jurnecka; Nela Klimova; Humaira Khaliq; Peter Sebo; Radim Osicka
Journal:  J Biol Chem       Date:  2020-05-11       Impact factor: 5.157

8.  Autophagy and Hsp70 activation alleviate oral epithelial cell death induced by food-derived hypertonicity.

Authors:  Ji Yang; Huijie Zhang; Sujiao Sun; Xue Wang; Ying Guan; Qili Mi; Wanli Zeng; Haiying Xiang; Huadong Zhu; Xin Zou; Yunfei You; Yang Xiang; Qian Gao
Journal:  Cell Stress Chaperones       Date:  2020-01-23       Impact factor: 3.667

Review 9.  Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins.

Authors:  Katerina Filipi; Waheed Ur Rahman; Adriana Osickova; Radim Osicka
Journal:  Microorganisms       Date:  2022-02-27

10.  Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins.

Authors:  Natalya Panova; Eva Zborníková; Ondřej Šimák; Radek Pohl; Milan Kolář; Kateřina Bogdanová; Renata Večeřová; Gabriela Seydlová; Radovan Fišer; Romana Hadravová; Hana Šanderová; Dragana Vítovská; Michaela Šiková; Tomáš Látal; Petra Lovecká; Ivan Barvík; Libor Krásný; Dominik Rejman
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.